Who owns BEAM?
Institutional ownership of Beam Therapeutics Inc. from Form 13F, Q2 2026
277 institutional managers reported holding Beam Therapeutics Inc. (BEAM) in Form 13F filings for Q2 2026, with 109,391,493 shares worth $3.8B. The largest reported holder was FMR LLC. Managers that filed both quarters added a net 1,106,040 shares (+1.0%). 56 opened new positions and 31 sold out.
- Funds holding
- 277
- Value held
- $3.8B
- New / sold out
- 56 / 31
- Net shares, same filers
- +1.0%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of BEAM
Share of 13F holdings is each fund's shares as a share of the 109,391,493 BEAM shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Morgan Stanley Added+$44.7M
- Contrarius Group Holdings Ltd Added+$37.1M
- Price T Rowe Associates Inc Added+$24.1M
- BlackRock, Inc. Added+$17.5M
- Jupiter Asset Management LTD Added+$14.5M
- BNP Paribas Financial Markets Added+$12.6M
- Vanguard Portfolio Management LLC Added+$12.0M
- Marshall Wace, LLP Added+$11.7M
- Foresite Capital Management VI LLC New+$11.3M
- Goldman Sachs Group Inc Added+$10.4M
Biggest sellers in Q2 2026
- ARK Investment Management LLC Trimmed-$65.2M
- ADAR1 Capital Management, LLC Sold out-$34.5M
- Qube Research & Technologies Ltd Trimmed-$30.6M
- Kynam Capital Management, LP Trimmed-$28.9M
- Sumitomo Mitsui Trust Group, Inc. Trimmed-$12.7M
- Amova Asset Management Americas, Inc. Trimmed-$12.7M
- Citadel Advisors LLC Sold out-$12.6M
- UBS Group AG Trimmed-$8.6M
- Peregrine Investment Management Inc Trimmed-$6.5M
- HRT Financial LP Sold out-$5.2M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $331M and sold $266M; 92 added and 75 trimmed.
Schedule 13D and 13G filings on BEAM
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-02-09STATE STREET CORP SCHEDULE 13G filed by Beam Therapeutics Inc.Schedule 13G
Questions about BEAM ownership
- Who owns BEAM stock?
- 277 institutional investment managers reported BEAM positions in their Form 13F filings for Q2 2026, holding 109,391,493 shares worth $3.8B in total. FMR LLC reported the largest position.
- Are funds buying or selling BEAM?
- In Q2 2026, 56 managers opened new BEAM positions, 92 added, 75 trimmed and 31 sold out. Managers that filed in both quarters added a net 1,106,040 shares.
- How current is this BEAM institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to BEAM by CUSIP. Options are left out. BEAM news and filings · BEAM insider trades · Top funds